Cargando…

Corrigendum to “Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma”

Detalles Bibliográficos
Autores principales:	Dong, Shuling, Yin, Huiqing, Dong, Cuicui, Sun, Kaiyan, Lv, Pin, Meng, Weiwei, Ming, Liang, He, Fucheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366225/ https://www.ncbi.nlm.nih.gov/pubmed/28386155 http://dx.doi.org/10.1155/2017/3437679

Ejemplares similares

Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma
por: Dong, Shuling, et al.
Publicado: (2016)

Corrigendum to “Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis”
por: Zhang, Hui, et al.
Publicado: (2017)

MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1
por: Wang, Ting, et al.
Publicado: (2023)

Corrigendum to ‘MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway’ [EBioMedicine 46 (2019) 66–78]
por: Wang, Wei-Wei, et al.
Publicado: (2020)

Corrigendum to “Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure”
por: Gao, Guangyuan, et al.
Publicado: (2022)

Corrigendum for The clinicopathological and microRNA expression signature associated with lymphovascular invasion in squamous cell carcinoma: a basic descriptive study
Publicado: (2022)

Corrigendum to: “Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study” [EBioMedicine 3 (216) 135–140]
por: Gisslén, Magnus, et al.
Publicado: (2016)

Corrigendum to “A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma”
por: Ip, Joseph Chok Yan, et al.
Publicado: (2016)

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”
por: Silveira, André C., et al.
Publicado: (2018)

[Corrigendum] Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells
por: Zhang, Wenqing, et al.
Publicado: (2023)

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1
por: Li, Hong-Lin, et al.
Publicado: (2023)

MicroRNA-216a-5p suppresses esophageal squamous cell carcinoma progression by targeting KIAA0101
por: Sun, Tuanhe, et al.
Publicado: (2020)

ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]
Publicado: (2022)

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
por: Xie, Yijun, et al.
Publicado: (2018)

Long Non-Coding RNA CASC2 Serves As A ceRNA Of microRNA-21 To Promote PDCD4 Expression In Oral Squamous Cell Carcinoma [Corrigendum]
Publicado: (2019)

MicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients
por: Kahng, Dong Hwahn, et al.
Publicado: (2022)

Corrigendum to “Plant MicroRNA Prediction by Supervised Machine Learning Using C5.0 Decision Trees”
por: Williams, Philip H., et al.
Publicado: (2017)

Corrigendum to: microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus
Publicado: (2023)

[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
por: Yang, Wei, et al.
Publicado: (2023)

Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum]
Publicado: (2021)

Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum]
Publicado: (2021)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

Corrigendum to “Percutaneous nephrolithotomy vs. extracorporeal shockwave lithotripsy for treating a 20–30 mm single renal pelvic stone” [Arab J. Urol. 13(3) (2015) 212–216]
por: Hassan, Mohammed, et al.
Publicado: (2016)

MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Corrigendum]
Publicado: (2021)

LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis [Corrigendum]
Publicado: (2021)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

Corrigendum to “Effect of Narrow-Band Ultraviolet B Phototherapy and Methotrexate on MicroRNA (146a) Levels in Blood of Psoriatic Patients”
por: Abou El-Fadle, Amal, et al.
Publicado: (2016)

Corrigendum to “MicroRNA-30-5p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21”
por: Zhou, Zhenyu, et al.
Publicado: (2021)

A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients
por: Suárez-Arriaga, Mayra-Cecilia, et al.
Publicado: (2018)

The Application and Influence of Hospice Care Among Patients with Advanced Esophageal Cancer [Corrigendum]
Publicado: (2022)

Corrigendum: treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy
Publicado: (2023)

Corrigendum to ‘microRNA-21a-5p/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma’
por: Su, Wenru, et al.
Publicado: (2023)

Polyethylenimine-based micro/nanoparticles as vaccine adjuvants [Corrigendum]
Publicado: (2017)

[Corrigendum] Human papillomavirus E6‑regulated microRNA‑20b promotes invasion in cervical cancer by targeting tissue inhibitor of metalloproteinase 2
por: Cheng, Yuan, et al.
Publicado: (2023)

Corrigendum to “SEC11A contributes to tumour progression of head and neck squamous cell carcinoma” [Heliyon 9(4) (April 2023) e14958]()
por: Shen, Hailong, et al.
Publicado: (2023)

Corrigendum to “mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19” [Gene Rep. 20 (2020) 100765]
por: Ramaiah, Mekala Janaki
Publicado: (2021)

Corrigendum: Comparative proteomes change and possible role in different pathways of microRNA-21a-5p in a mouse model of spinal cord injury
Publicado: (2020)

Transcriptome dynamics of the microRNA inhibition response
por: Wen, Jiayu, et al.
Publicado: (2016)

Corrigendum to “Anticancer Effects of Salvia miltiorrhiza Alcohol Extract on Oral Squamous Carcinoma Cells”
por: Wang, Wen-Hung, et al.
Publicado: (2017)

Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma
por: Cui, Yuantao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4aeatu3454h6sfpj6o9pk6erb5